Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Real-world correlation of RFS and OS in early-stage hepatocellular carcinoma treated with curative intent: A retrospective analysis of SEER-Medicare data.
Authors
Neil Mehta
University of California, San Francisco, San Francisco, CA
Neil Mehta , Kaushal Desai , Shital Kamble , Yan Song , Emily Gao , Usha Malhotra , Angela Lax , Sanjana Sundaresan , Nathaniel Downes , Adina Zhang , Abby B. Siegel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 451)
DOI
10.1200/JCO.2024.42.3_suppl.451
Abstract #
451
Poster Bd #
A16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC).
First Author: Arndt Vogel
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world clinical characteristics and treatment patterns among people with hepatocellular carcinoma in the United States (US) treated with resection or ablation.
First Author: Neehar Parikh
Poster
2024 ASCO Annual Meeting
Utilization of tumor-informed circulating tumor DNA in detecting minimal residual disease and guiding adjuvant therapy in liver cancer.
First Author: De-Zhen Guo
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Therapeutic effectiveness of high-intensity focused ultrasound (HIFU) ablation in patients with unresectable hepatocellular carcinoma.
First Author: Jin Il Kim